1. Home
  2. IVA vs BAER Comparison

IVA vs BAER Comparison

Compare IVA & BAER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVA
  • BAER
  • Stock Information
  • Founded
  • IVA 2011
  • BAER 2014
  • Country
  • IVA France
  • BAER United States
  • Employees
  • IVA N/A
  • BAER N/A
  • Industry
  • IVA Biotechnology: Pharmaceutical Preparations
  • BAER Blank Checks
  • Sector
  • IVA Health Care
  • BAER Finance
  • Exchange
  • IVA Nasdaq
  • BAER Nasdaq
  • Market Cap
  • IVA 359.6M
  • BAER 100.7M
  • IPO Year
  • IVA 2020
  • BAER N/A
  • Fundamental
  • Price
  • IVA $3.01
  • BAER $1.97
  • Analyst Decision
  • IVA Strong Buy
  • BAER Strong Buy
  • Analyst Count
  • IVA 4
  • BAER 1
  • Target Price
  • IVA $10.50
  • BAER $5.25
  • AVG Volume (30 Days)
  • IVA 18.3K
  • BAER 232.5K
  • Earning Date
  • IVA 03-26-2025
  • BAER 08-11-2025
  • Dividend Yield
  • IVA N/A
  • BAER N/A
  • EPS Growth
  • IVA N/A
  • BAER N/A
  • EPS
  • IVA N/A
  • BAER N/A
  • Revenue
  • IVA $14,591,573.00
  • BAER $108,752,000.00
  • Revenue This Year
  • IVA $15.38
  • BAER $13.26
  • Revenue Next Year
  • IVA $24.22
  • BAER N/A
  • P/E Ratio
  • IVA N/A
  • BAER N/A
  • Revenue Growth
  • IVA N/A
  • BAER 51.36
  • 52 Week Low
  • IVA $1.53
  • BAER $1.02
  • 52 Week High
  • IVA $4.05
  • BAER $4.44
  • Technical
  • Relative Strength Index (RSI)
  • IVA 40.84
  • BAER 60.59
  • Support Level
  • IVA $3.00
  • BAER $1.55
  • Resistance Level
  • IVA $3.23
  • BAER $2.11
  • Average True Range (ATR)
  • IVA 0.21
  • BAER 0.14
  • MACD
  • IVA -0.04
  • BAER 0.01
  • Stochastic Oscillator
  • IVA 5.08
  • BAER 66.07

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

About BAER Bridger Aerospace Group Holdings Inc.

Bridger Aerospace Group Holdings Inc operates as an aerial firefighting company. It provides aerial wildfire surveillance, relief and suppression, and aerial firefighting services using next-generation technology and environmentally friendly and sustainable firefighting methods. Bridger Aerospace provides aerial firefighting and wildfire management services to federal and state government agencies, including the United States Forest Service, across the nation. The company's portfolio is organized across two offerings: Fire Suppression, which Consists of deploying specialized Viking CL-415EAF (Super Scooper) aircraft to drop large amounts of water quickly and directly on wildfires, and Aerial Surveillance, providing aerial surveillance via manned aircraft for fire suppression aircraft.

Share on Social Networks: